Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.

P, Lemoine; C, Guilleminault; E, Alvarez

doi:10.4088/jcp.v68n1112

Public

Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.

Shared by NobleBlocks on Nov 1, 2007 • 12:00 AM UTC

Authors:

Lemoine P

Guilleminault C

Alvarez E

Abstract

Objective Patients with major depressive disorder (MDD) experience sleep disturbances that may be worsened by some antidepressant drugs early in treatment. The aim of this study was to assess the subjective quality of sleep of patients receiving agomelatine, a new antidepressant with melatonergic MT...

Discussions